Charles O. Noble, Ph.D.
Affiliations: | ZoneOne Pharma |
Area:
Analytical ChemistryGoogle:
"Charles Noble"Mean distance: 9.37 | S | N | B | C | P |
Parents
Sign in to add mentor| Robin L. McCarley | grad student | 2001 | Louisiana State | |
| (Pyrrole -terminated dendrimers for use in polymerizable monolayers and guest encapsulation systems.) | ||||
| Daryl C. Drummond | post-doc | LSU | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kirpotin DB, Hayes ME, Noble CO, et al. (2022) Drug Stability and Minimized Acid-/Drug-Catalyzed Phospholipid Degradation in Liposomal Irinotecan. Journal of Pharmaceutical Sciences |
| Huang ZR, Tipparaju SK, Kirpotin DB, et al. (2019) Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Kamoun WS, Kirpotin DB, Huang ZR, et al. (2019) Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models. Nature Biomedical Engineering. 3: 264-280 |
| Tang J, Srinivasan S, Yuan W, et al. (2018) Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V |
| Louis N, Liu S, He X, et al. (2017) New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. Journal of Neuro-Oncology |
| Clarke JL, Molinaro AM, Cabrera JR, et al. (2017) A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemotherapy and Pharmacology |
| Yuan W, Kuai R, Dai Z, et al. (2016) Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes. The Aaps Journal |
| Kirpotin DB, Tipparaju S, Huang ZR, et al. (2016) Abstract 3912: MM-310, a novel EphA2-targeted docetaxel nanoliposome Cancer Research. 76: 3912-3912 |
| Noble CO, Krauze MT, Drummond DC, et al. (2014) Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors. Nanomedicine (London, England). 9: 2099-108 |
| Weng KC, Hashizume R, Noble CO, et al. (2013) Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine (London, England). 8: 1913-25 |